| Financial Year |
March 31 2023 |
| Monetary Funds |
843,793,979.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
246,426,371.86 |
| Accounts Receivable |
2,605,431,211.79 |
| Advances to Suppliers |
195,254,221.50 |
| Other Receivables |
13,494,367.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,096,795,730.05 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
180,026,535.20 |
| Total Current Assets |
5,218,963,416.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
23,143,733.38 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,542,071,215.11 |
| Under-construction Projects |
1,154,467,626.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
203,515,057.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,298,527.11 |
| Deferred Income Tax Assets |
66,314,106.44 |
| Other Non-Current Assets |
603,869,218.11 |
| Sub-Total of Non-Current Assets |
5,730,156,469.75 |
| Total Assets |
10,949,119,886.67 |
| Short-Term Loans |
1,100,637,694.44 |
| Trading Financial liabilities |
-- |
| Notes Payable |
505,910,116.01 |
| Accounts Payable |
757,141,507.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,216,108.74 |
| Taxes Payable |
34,197,593.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,677,390.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
426,206,852.98 |
| Other Current Liabilities |
110,436,100.24 |
| Sub-Total of Current Liabilities |
3,241,792,813.25 |
| Long-term Loans |
1,857,022,499.97 |
| Bonds Payable |
647,110,408.41 |
| Long-Term Accounts Payable |
995,544,447.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
9,888,550.00 |
| Deferred Income Tax Liabilities |
64,995.36 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,610,074,553.33 |
| Total Liabilities |
6,851,867,366.58 |
| Paid-In Capital(Or Share Stock) |
809,299,439.00 |
| Capital Surplus |
1,328,722,243.84 |
| Surplus Reserve |
161,015,348.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,626,905,220.70 |
| Minority Stockholder's Interest |
41,253,331.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,055,999,188.79 |
| Owner's Equity（Stockholder's Equity） |
4,097,252,520.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,949,119,886.67 |
